Search research articles
Contact Us
Filters
Showing results (31-40 of 36) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 36 results.
BMC Pulmonary Medicine
|
February 19, 2017
Elderly-onset hereditary pulmonary alveolar proteinosis and its cytokine profile
Masayuki Ito, Kazuyuki Nakagome, Hiromitsu Ohta, et al.
Pulmonary Medicine
|
June 4, 2011
Gradual increase of high mobility group protein b1 in the lungs after the onset of acute exacerbation of idiopathic pulmonary fibrosis
Masahito Ebina, Hiroyuki Taniguchi, Taku Miyasho, et al.
American Journal of Respiratory and Critical Care Medicine
|
March 1, 2005
Granulocyte-macrophage colony-stimulating factor and lung immunity in pulmonary alveolar proteinosis
Ryushi Tazawa, Emi Hamano, Toru Arai, et al.
Thoracic Cancer
|
July 20, 2023
Using the neutrophil-to-lymphocyte ratio to predict the outcome of individuals with nonsquamous non-small cell lung cancer receiving pembrolizumab plus platinum and pemetrexed
Hisao Imai, Satoshi Wasamoto, Takeshi Tsuda, et al.
Oncology
|
August 20, 2023
Prognostic Potential of the Prognostic Nutritional Index in Non-Small Cell Lung Cancer Patients Receiving Pembrolizumab Combination Therapy with Carboplatin and Paclitaxel/Nab-Paclitaxel
Fuyumi Nishihara-Kato, Hisao Imai, Takeshi Tsuda, et al.
Respiratory Investigation
|
August 5, 2019
Summary of the Japanese Respiratory Society statement for the treatment of lung cancer with comorbid interstitial pneumonia
Takashi Ogura, Nagio Takigawa, Keisuke Tomii, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 36) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 36 results.
BMC Pulmonary Medicine
|
February 19, 2017
Elderly-onset hereditary pulmonary alveolar proteinosis and its cytokine profile
Masayuki Ito, Kazuyuki Nakagome, Hiromitsu Ohta, et al.
Pulmonary Medicine
|
June 4, 2011
Gradual increase of high mobility group protein b1 in the lungs after the onset of acute exacerbation of idiopathic pulmonary fibrosis
Masahito Ebina, Hiroyuki Taniguchi, Taku Miyasho, et al.
American Journal of Respiratory and Critical Care Medicine
|
March 1, 2005
Granulocyte-macrophage colony-stimulating factor and lung immunity in pulmonary alveolar proteinosis
Ryushi Tazawa, Emi Hamano, Toru Arai, et al.
Thoracic Cancer
|
July 20, 2023
Using the neutrophil-to-lymphocyte ratio to predict the outcome of individuals with nonsquamous non-small cell lung cancer receiving pembrolizumab plus platinum and pemetrexed
Hisao Imai, Satoshi Wasamoto, Takeshi Tsuda, et al.
Oncology
|
August 20, 2023
Prognostic Potential of the Prognostic Nutritional Index in Non-Small Cell Lung Cancer Patients Receiving Pembrolizumab Combination Therapy with Carboplatin and Paclitaxel/Nab-Paclitaxel
Fuyumi Nishihara-Kato, Hisao Imai, Takeshi Tsuda, et al.
Respiratory Investigation
|
August 5, 2019
Summary of the Japanese Respiratory Society statement for the treatment of lung cancer with comorbid interstitial pneumonia
Takashi Ogura, Nagio Takigawa, Keisuke Tomii, et al.
Page
of 4